title: High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI.
abstract: The role of high density lipoprotein (HDL) phospholipid in scavenger receptor BI (SR-BI)-mediated free cholesterol flux was examined by manipulating HDL(3) phosphatidylcholine and sphingomyelin content. Both phosphatidylcholine and sphingomyelin enrichment of HDL enhanced the net efflux of cholesterol from SR-BI-expressing COS-7 cells but by two different mechanisms. Phosphatidylcholine enrichment of HDL increased efflux, whereas sphingomyelin enrichment decreased influx of HDL cholesterol. Although similar trends were observed in control (vector-transfected) COS-7 cells, SR-BI overexpression amplified the effects of phosphatidylcholine and sphingomyelin enrichment of HDL 25- and 2.8-fold, respectively. By using both phosphatidylcholine-enriched and phospholipase A(2)-treated HDL to obtain HDL with a graded phosphatidylcholine content, we showed that SR-BI-mediated cholesterol efflux was highly correlated (r(2) = 0.985) with HDL phosphatidylcholine content. The effects of varying HDL phospholipid composition on SR-BI-mediated free cholesterol flux were not correlated with changes in either the K(d) or B(max) values for high affinity binding to SR-BI. We conclude that SR-BI-mediated free cholesterol flux is highly sensitive to HDL phospholipid composition. Thus, factors that regulate cellular SR-BI expression and the local modification of HDL phospholipid composition will have a large impact on reverse cholesterol transport.
authors.affiliation: Division of Gastroenterology and Nutrition, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
authors.forename: P G
authors.initials: PG
authors.lastname: Yancey
authors.forename: M
authors.initials: M
authors.lastname: de la Llera-Moya
authors.forename: S
authors.initials: S
authors.lastname: Swarnakar
authors.forename: P
authors.initials: P
authors.lastname: Monzo
authors.forename: S M
authors.initials: SM
authors.lastname: Klein
authors.forename: M A
authors.initials: MA
authors.lastname: Connelly
authors.forename: W J
authors.initials: WJ
authors.lastname: Johnson
authors.forename: D L
authors.initials: DL
authors.lastname: Williams
authors.forename: G H
authors.initials: GH
authors.lastname: Rothblat
mesh_terms: D000818:Animals; D018955:CD36 Antigens / Q000378:metabolism*; D019556:COS Cells; D002784:Cholesterol / Q000378:metabolism*; D007700:Kinetics; D008075:Lipoproteins, HDL / Q000737:chemistry* / Q000378:metabolism; D053439:Lipoproteins, HDL2; D053440:Lipoproteins, HDL3; D008565:Membrane Proteins; D010713:Phosphatidylcholines / Q000378:metabolism; D010741:Phospholipases A / Q000378:metabolism; D010743:Phospholipids / Q000737:chemistry*; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein / Q000378:metabolism*; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D013109:Sphingomyelins / Q000378:metabolism; D014162:Transfection
chemical_list: D018955:CD36 Antigens; D008075:Lipoproteins, HDL; D053439:Lipoproteins, HDL2; D053440:Lipoproteins, HDL3; D008565:Membrane Proteins; D010713:Phosphatidylcholines; D010743:Phospholipids; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; D013109:Sphingomyelins; D002784:Cholesterol; D010741:Phospholipases A